# A Study of Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer

> **NCT03144466** · PHASE1 · TERMINATED · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 1 (actual)

## Conditions studied

- Cervix Cancer

## Interventions

- **COMBINATION_PRODUCT:** Pembrolizumab

## Key facts

- **NCT ID:** NCT03144466
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-18
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-01-31
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Slow recruitment.
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03144466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03144466, "A Study of Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03144466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*